Regenxbio RGNX Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regenxbio's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regenxbio's accretion (amortization) of discounts and premiums, investments?
- Regenxbio (RGNX) reported accretion (amortization) of discounts and premiums, investments of $879K in Q1 2026.
- How has Regenxbio's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Regenxbio's accretion (amortization) of discounts and premiums, investments decreased by 17.9% year-over-year, from $1.07M to $879K.
- What is the long-term trend for Regenxbio's accretion (amortization) of discounts and premiums, investments?
- Over 3 years (2021 to 2025), Regenxbio's accretion (amortization) of discounts and premiums, investments has grown at a -2.1% compound annual growth rate (CAGR), from -$5.84M to $5.48M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This reflects the non-cash adjustment to the carrying value of investment securities purchased at a price different from their face value. It systematically recognizes the discount or premium over the life of the investment to align the book value with the maturity value. This metric is essential for understanding the true yield and interest income generated by the company's investment portfolio.